No full marketing authorisation yet for Covishield and Covaxin vaccines

Review process to continue, experts studying data submitted

Covaxin, Covishield, serum institute of india, bharat biotech, vaccine, vaccination, coronavirus, covid

Premium

Mumbai

3 min read Last Updated : Jan 15 2022 | 0:39 AM IST

There is still some time till Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin get full marketing authorisation from India’s drug regulator.

According to government sources, the review process is

Topics : Coronavirus Vaccine Bharat Biotech Serum Institute of India

First Published: Jan 14 2022 | 8:38 PM IST

Explore News

Stock Market Updates World Heart Day 2023 Asian Games 2023 Kabaddi schedule Latest News Live Asian Games LIVE updates India Cricket World Cup Squad Hookah Ban in Haryana Gold-Silver Price MCX Share Price Asian Games 2023 September 30 schedule

Companies News

Air India completes acquisition of its 1st A350 aircraft through GIFT City Jalan Kalrock Consortium infuses Rs 100 crore in cash-strapped Jet Airways

Sports News

Asian Games 2023 September 30 schedule: India event timings, streaming Asian Games Day 6 Highlights: Historic shot put medal push IND tally to 33

India News

Punjab farmers continue three-day 'rail roko' agitation over MSP demand War in Ukraine pushes India to obtain more self-propelled guns to arsenal

Economy News

Adani partnership remains steadfast: IHC on Adani units' stake sale Sugar market eyes restrictions from India after lower monsoon rains

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Continue

No full marketing authorisation yet for Covishield and Covaxin vaccines

Review process to continue, experts studying data submitted

Also Read

Bharat Biotech injects pace into Covid-19 vaccine Covaxin supply

Bharat Biotech's Covaxin set to go global after WHO gives it a booster

CMC Vellore calls for volunteers for Covaxin vaccine booster dose trials

What is the controversy surrounding Serum Institute's Covishield and EMA?

Serum Institute applies for full marketing authorisation of Covishield

CISF worst-hit by Covid-19 among all CAPFs due to airport duties

Covid-19 pandemic:10,307 fresh cases and 3 more deaths in Rajasthan

Covid-19 pandemic: Nashik sees 1,996 cases, active tally reaches 8,721

Bengal logs 22,645 new Covid-19 cases, 28 deaths; fatality rate 1.07%

Karnataka reports 28,723 new Covid-19 cases, 20,121 in Bengaluru

Explore News